// company-profile

DBV Technologies S.A.

DBVT
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.I0Filings28Insiders19
// api This DBV Technologies S.A. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for DBVT in the last 90 days.

Institutional Ownership

Top 13F-HR holders of DBV Technologies S.A. as of 2026-03-31

↑ increasing
Total reported AUM
$424.8M
QoQ change
+40.6%
Reporting period
2026-03-31
#1
MPM BIOIMPACT LLC
CIK 1687078
$108.9M
5.2M shares
#2
Vivo Capital, LLC
CIK 1674712
$55.7M
2.7M shares
#3
Artisan Partners Limited Partnership
CIK 1466153
$46.4M
2.2M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jan 29, 2026Mohideen PharisDBVT
Sale
534$4.86$3K
Jan 12, 2026BAKER BROS. ADVISORS LPDBVT
Option Exercise
25,005,240$0.00$0K
Jan 12, 2026BAKER BROS. ADVISORS LPDBVT
Option Exercise
2,299,656$0.00$0K
Jan 12, 2026BAKER BROS. ADVISORS LPDBVT
Option Exercise
2,299,656$0.00$0K
Jan 12, 2026BAKER BROS. ADVISORS LPDBVT
Option Exercise
25,005,240$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.